V010-1637 Screening compound: 2-[(4-{1-phenyl-6-propyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl}-1,4-diazepan-1-yl)methyl]phenol

V010-1637 Screening compound: 2-[(4-{1-phenyl-6-propyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl}-1,4-diazepan-1-yl)methyl]phenol
V010-1637 Screening compound: 2-[(4-{1-phenyl-6-propyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl}-1,4-diazepan-1-yl)methyl]phenol alternative view

Chemical Structure Depiction of ChemDiv screening compound V010-1637
2-[(4-{1-phenyl-6-propyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl}-1,4-diazepan-1-yl)methyl]phenol

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V010-1637

Molecular Formula

C26H30N6O (C26 H30 N6 O)

Compound Name

2-[(4-{1-phenyl-6-propyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl}-1,4-diazepan-1-yl)methyl]phenol

IUPAC name

2-[(4-{1-phenyl-6-propyl-1H-pyrazolo[34-d]pyrimidin-4-yl}-14-diazepan-1-yl)methyl]phenol

SMILES

CCCc1nc(n(-c2ccccc2)nc2)c2c(N2CCN(Cc(cccc3)c3O)CCC2)n1

InChI

InChI=1S/C26H30N6O/c1-2-9-24-28-25(22-18-27-32(26(22)29-24)21-11-4-3-5-12-21)31-15-8-14-30(16-17-31)19-20-10-6-7-13-23(20)33/h3-7,10-13,18,33H,2,8-9,14-17,19H2,1H3

InChI Key

BXLYZCGRZZGRRU-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19859027

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

442.56

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

5.262

Distribution Coefficient, logD

5.109

Water Solubility, LogSw

-4.97

Polar Surface Area

58.032

Acid Dissociation Constant (pKa)

10.53

Base Dissociation Constant (pKb)

7.02

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

34.60

V010-1637 in Drug Discovery

Included in Screening Libraries

Adenosine Receptors Targeted Library (19896 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with V010-1637 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V010-1637?
Check Price and Availability of V010-1637, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V010-1637 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V010-1637
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V010-1637
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V010-1637 available by request